The goal of this program is to improve the management of breast cancer. After hearing and assimilating this program, the clinician will be better able to:
1. Elaborate on the potential advantages of neoadjuvant systemic therapy for breast cancer.
2. Identify patients most likely to benefit from neoadjuvant chemotherapy for breast cancer.
3. Cite current literature on emerging neoadjuvant breast cancer therapies.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Obstetrics-and-Gynecology
- Start Date: 2022-02-24 06:00:00
- End Date: 2022-02-24 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest